Note: Though Dostarlimab is a breakthrough is the medical science for rectal cancer patients but as of now it is applicable to 4 to 5% cases of rectal cancer with mismatch deficient repair type.

#thefamilydoc #cancer #dostarlimab #usa #healthservices #familydoctor #healthprofessionals #healthcareprofessional #medicalcare #medical #heathcare #india #healthcare #doctor #health #wellness #treatment #cure #cancercare #trending #unitedstates #cancerawareness #cancerdrug #medical #medicine #usdrugtrial

source